Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
CANCER DISCOVERY
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
. 13:2370-2393.
2023
Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors
. 2:458-471.
2012
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway
. 1:442-456.
2011
Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy
2020
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways (vol 13, pg 2370, 2023)
2025
Research
category
ONCOLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
2159-8274
Electronic International Standard Serial Number (EISSN)
2159-8290
Other
journal abbreviation
CANCER DISCOV
